Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B
Open Access
- 5 August 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 33 (25), 3298-3306
- https://doi.org/10.1038/onc.2013.293
Abstract
Despite the progress made in targeted anticancer therapies in recent years, challenges remain. The identification of new potential targets will ensure that the arsenal of cancer therapies continues to expand. FAM83B was recently discovered in a forward genetic screen for novel oncogenes that drive human mammary epithelial cell (HMEC) transformation. We report here that elevated FAM83B expression increases Phospholipase D (PLD) activity, and that suppression of PLD1 activity prevents FAM83B-mediated transformation. The increased PLD activity is engaged by hyperactivation of epidermal growth factor receptor (EGFR), which is regulated by an interaction involving FAM83B and EGFR. Preventing the FAM83B/EGFR interaction by site-directed mutation of lysine 230 of FAM83B suppressed PLD activity and MAPK signaling. Furthermore, ablation of FAM83B expression from breast cancer cells inhibited EGFR phosphorylation and suppressed cell proliferation. We propose that understanding the mechanism of FAM83B-mediated transformation will provide a foundation for future therapies aimed at targeting its function as an intermediary in EGFR, MAPK and mTOR activation.Keywords
This publication has 41 references indexed in Scilit:
- FAM83B mediates EGFR- and RAS-driven oncogenic transformationJCI Insight, 2012
- FAM83A confers EGFR-TKI resistance in breast cancer cells and in miceJCI Insight, 2012
- Phospholipase D: Enzymology, Functionality, and Chemical ModulationChemical Reviews, 2011
- Phosphatidic acid signaling to mTOR: Signals for the survival of human cancer cellsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- Regulation of mTORC1 and mTORC2 Complex Assembly by Phosphatidic Acid: Competition with RapamycinMolecular and Cellular Biology, 2009
- Role of Phosphatidic Acid in the Coupling of the ERK CascadeJournal of Biological Chemistry, 2008
- Cotargeting survival signaling pathways in cancerJCI Insight, 2008
- Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse modelJCI Insight, 2008
- Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancerJCI Insight, 2008
- Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-RasCancer Letters, 2007